DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Motzer RJ. et al.
IMmotion151: A randomized phase III study of atezolizumab plus bevacizumab versus suntinib in untreated metastatic renal cell carcinoma.
2018 (abstr 578; Abstract nur über Website des ASCO GU veröffentlicht)
Access:
We do not assume any responsibility for the contents of the web pages of other providers.